Status:
UNKNOWN
Evaluation of Central Macular Thickness in Femtosecond Laser-assisted Cataract Surgery
Lead Sponsor:
Medical University of Vienna
Conditions:
Age Related Cataracts
Cystoid Macular Edema
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
The investigational device is an approved femtosecond laser (FSL) device with an integrated imaging system to perform certain steps of the cataract procedure. The FSL will perform anterior capsulotomy...
Eligibility Criteria
Inclusion
- Bilateral Age-related cataract necessitating lens extraction and posterior IOL implantation
- Age 40 and older (females of childbearing age will be interviewed if pregnancy is possible)
Exclusion
- Corneal abnormality
- Preceding ocular surgery or trauma
- Uncontrolled glaucoma
- Proliferative diabetic retinopathy
- Macular degeneration
- Iris neovascularization
- History of uveitis/iritis
- Microphthalmus
- Recurrent intraocular inflammation of unknown etiology
- Blind fellow eye
- Uncontrolled systemic or ocular disease
Key Trial Info
Start Date :
March 26 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 6 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03465124
Start Date
March 26 2018
End Date
April 6 2019
Last Update
March 7 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Austria, 1090